nach oben

Current Reviews in Musculoskeletal Medicine

Erschienen in:

26.09.2018 | Protein-Rich Plasma: From Bench to Treatment of Arthritis (S Choate and J Tokish, section editors)

Platelet-rich plasma in the foot and ankle

verfasst von: Peter R. Henning, Benjamin J. Grear

Erschienen in: Current Reviews in Musculoskeletal Medicine | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Platelet-rich plasma has become an increasingly popular treatment option within the orthopedic community to biologically enhance and stimulate difficult-to-heal musculoskeletal tissues. This review evaluates the recent literature on platelet-rich plasma use in the treatment of foot and ankle pathologies.

Recent findings

Recent literature has demonstrated platelet-rich plasma to have a possible benefit in the treatment of Achilles pathology, chronic plantar fasciitis, osteochondral lesions of the talus, ankle osteoarthritis, and diabetic foot ulcers. However, given the lack of standardization of platelet-rich plasma preparations and protocols and the predominance of low-quality studies, no definitive treatment indications exist.

Summary

Platelet-rich plasma is a promising treatment option, but at present, there is only limited clinical evidence supporting its use in foot and ankle applications.

Alves R, Grimalt R. A review of platelet-rich plasma: history, biology, mechanism of action, and classification. Skin Appendage Disord. 2018;4(1):18–24. https://doi.org/10.1159/000477353.CrossRefPubMed

Andia E R-AJ, Martin I, Abate M. Current concepts and translational uses of platelet rich plasma biotechnology. Biotechnology 2015. https://doi.org/10.5772/59954.

Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17(10):602–8.CrossRef

Administration FaD. Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products. Minimal manipulation and homologous use. In: Services USDoHaH, editor. Maryland: U.S. Department of Health and Human Services. p. 2017.

Mishra A, Tummala P, King A, Lee B, Kraus M, Tse V, et al. Buffered platelet-rich plasma enhances mesenchymal stem cell proliferation and chondrogenic differentiation. Tissue Engineering Part C, Methods. 2009;15(3):431–5. https://doi.org/10.1089/ten.tec.2008.0534.CrossRefPubMedPubMedCentral

Murray IR, LaPrade RF. Platelet-rich plasma: renewed scientific understanding must guide appropriate use. Bone Joint Res. 2016;5(3):92–4. https://doi.org/10.1302/2046-3758.53.Bjr-2016-0005.CrossRefPubMedPubMedCentral

Prins HJ, Rozemuller H, Vonk-Griffioen S, Verweij VG, Dhert WJ, Slaper-Cortenbach IC, et al. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum. Tissue Eng A. 2009;15(12):3741–51. https://doi.org/10.1089/ten.TEA.2008.0666.CrossRef

Zaky SH, Ottonello A, Strada P, Cancedda R, Mastrogiacomo M. Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med. 2008;2(8):472–81. https://doi.org/10.1002/term.119.CrossRefPubMed

Dolkart O, Chechik O, Zarfati Y, Brosh T, Alhajajra F, Maman E. A single dose of platelet-rich plasma improves the organization and strength of a surgically repaired rotator cuff tendon in rats. Arch Orthop Trauma Surg. 2014;134(9):1271–7. https://doi.org/10.1007/s00402-014-2026-4.CrossRefPubMed

10.

Iqbal J, Pepkowitz SH, Klapper E. Platelet-rich plasma for the replenishment of bone. Curr Osteoporos Rep. 2011;9(4):258–63. https://doi.org/10.1007/s11914-011-0080-1.CrossRefPubMed

11.

Castillo TN, Pouliot MA, Kim HJ, Dragoo JL. Comparison of growth factor and platelet concentration from commercial platelet-rich plasma separation systems. Am J Sports Med. 2011;39(2):266–71. https://doi.org/10.1177/0363546510387517.CrossRefPubMed

12.

Fitzpatrick J, Bulsara MK, McCrory PR, Richardson MD, Zheng MH. Analysis of platelet-rich plasma extraction: variations in platelet and blood components between 4 common commercial kits. Orthop J Sports Med. 2017;5(1):2325967116675272. https://doi.org/10.1177/2325967116675272.CrossRefPubMedPubMedCentral

13.

Oh JH, Kim W, Park KU, Roh YH. Comparison of the cellular composition and cytokine-release kinetics of various platelet-rich plasma preparations. Am J Sports Med. 2015;43(12):3062–70. https://doi.org/10.1177/0363546515608481.CrossRefPubMed

14.

Weibrich G, Kleis WK, Streckbein P, Moergel M, Hitzler WE, Hafner G. Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma). Int J Oral Maxillofac Implants. 2012;27(4):762–9.PubMed

15.

Sundman EA, Cole BJ, Fortier LA. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med. 2011;39(10):2135–40. https://doi.org/10.1177/0363546511417792.CrossRefPubMed

16.

Mazzocca AD, McCarthy MB, Chowaniec DM, Cote MP, Romeo AA, Bradley JP, et al. Platelet-rich plasma differs according to preparation method and human variability. J Bone Joint Surg Am. 2012;94(4):308–16. https://doi.org/10.2106/jbjs.K.00430.CrossRefPubMed

17.

McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg American volume. 2012;94(19):e143(1–8). doi:https://doi.org/10.2106/jbjs.L.00019, e14e1438).CrossRef

18.

Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion. 1995;35(2):117–24.CrossRef

19.

Stack G, Snyder EL. Cytokine generation in stored platelet concentrates. Transfusion. 1994;34(1):20–5.CrossRef

20.

Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion. 1993;33(3):195–9.CrossRef

21.

Hilber F, Loibl M, Lang S, Kerschbaum M, Brockhoff G, Angele P, et al. Leukocyte-reduced platelet-rich plasma increases proliferation of tenocytes treated with prednisolone: a cell cycle analysis. Arch Orthop Trauma Surg. 2017;137(10):1417–22. https://doi.org/10.1007/s00402-017-2771-2.CrossRefPubMed

22.

Wang SZ, Fan WM, Jia J, Ma LY, Yu JB, Wang C. Is exclusion of leukocytes from platelet-rich plasma (PRP) a better choice for early intervertebral disc regeneration? Stem Cell Res Ther. 2018;9(1):199. https://doi.org/10.1186/s13287-018-0937-7.CrossRefPubMedPubMedCentral

23.

Zhang L, Chen S, Chang P, Bao N, Yang C, Ti Y, et al. Harmful effects of leukocyte-rich platelet-rich plasma on rabbit tendon stem cells in vitro. Am J Sports Med. 2016;44(8):1941–51. https://doi.org/10.1177/0363546516644718.CrossRefPubMed

24.

Yan R, Gu Y, Ran J, Hu Y, Zheng Z, Zeng M, et al. Intratendon delivery of leukocyte-poor platelet-rich plasma improves healing compared with leukocyte-rich platelet-rich plasma in a rabbit Achilles tendinopathy model. Am J Sports Med. 2017;45(8):1909–20. https://doi.org/10.1177/0363546517694357.CrossRef

25.

Boswell SG, Schnabel LV, Mohammed HO, Sundman EA, Minas T, Fortier LA. Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons. Am J Sports Med. 2014;42(1):42–9. https://doi.org/10.1177/0363546513507566.CrossRefPubMed

26.

Cross JA, Cole BJ, Spatny KP, Sundman E, Romeo AA, Nicholson GP, et al. Leukocyte-reduced platelet-rich plasma normalizes matrix metabolism in torn human rotator cuff tendons. Am J Sports Med. 2015;43(12):2898–906. https://doi.org/10.1177/0363546515608157.CrossRefPubMed

27.

Filardo G, Kon E, Pereira Ruiz MT, Vaccaro F, Guitaldi R, Di Martino A et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc : official journal of the ESSKA. 2012;20(10):2082–2091. doi:https://doi.org/10.1007/s00167-011-1837-x.CrossRef

28.

Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. Am J Sports Med. 2014;42(5):1204–10. https://doi.org/10.1177/0363546514525593.CrossRefPubMedPubMedCentral

29.

Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ. Effect of leukocyte concentration on the efficacy of platelet-rich plasma in the treatment of knee osteoarthritis. Am J Sports Med. 2016;44(3):792–800. https://doi.org/10.1177/0363546515580787.CrossRef

30.

de Jonge S, de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med. 2011;39(8):1623–9. https://doi.org/10.1177/0363546511404877.CrossRefPubMed

31.

Kearney RS, Parsons N, Costa ML. Achilles tendinopathy management: a pilot randomised controlled trial comparing platelet-richplasma injection with an eccentric loading programme. Bone Joint Res. 2013;2(10):227–32. https://doi.org/10.1302/2046-3758.210.2000200.CrossRefPubMedPubMedCentral

32.

Krogh TP, Ellingsen T, Christensen R, Jensen P, Fredberg U. Ultrasound-guided injection therapy of Achilles tendinopathy with platelet-rich plasma or saline: a randomized, blinded, placebo-controlled trial. Am J Sports Med. 2016;44(8):1990–7. https://doi.org/10.1177/0363546516647958.CrossRefPubMed

33.

de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010;303(2):144–9. https://doi.org/10.1001/jama.2009.1986.CrossRefPubMed

34.

Boesen AP, Hansen R, Boesen MI, Malliaras P, Langberg H. Effect of high-volume injection, platelet-rich plasma, and sham treatment in chronic midportion Achilles tendinopathy: a randomized double-blinded prospective study. Am J Sports Med. 2017;45(9):2034–43. https://doi.org/10.1177/0363546517702862.CrossRef

35.

• Zhang YJ, Xu SZ, Gu PC, Du JY CYZ, Zhang C, et al. Is platelet-rich plasma injection effective for chronic Achilles tendinopathy? A meta-analysis. Clin Orthop Relat Res. 2018. https://doi.org/10.1007/s11999.0000000000000258 Meta-analysis and systematic review of a total of 170 patients with chronic Achilles tendinopathy enrolled in either a PRP injection plus eccentric strengthening group or a saline injection plus eccentric strengthening group were evaluated. The authors found no significant difference between the PRP and saline groups regarding Victorian Institute of Sports Assessment-Achilles scores, ultrasonographic evaluation of tendon thickness, or ultrasound color Doppler activity. CrossRef

36.

Guelfi M, Pantalone A, Vanni D, Abate M, Guelfi MG, Salini V. Long-term beneficial effects of platelet-rich plasma for non-insertional Achilles tendinopathy. Foot Ankle Surg. 2015;21(3):178–81. https://doi.org/10.1016/j.fas.2014.11.005.CrossRefPubMed

37.

Monto RR. Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int. 2012;33(5):379–85. https://doi.org/10.3113/fai.2012.0379.CrossRefPubMed

38.

Wilkins R, Bisson LJ. Operative versus nonoperative management of acute Achilles tendon ruptures: a quantitative systematic review of randomized controlled trials. Am J Sports Med. 2012;40(9):2154–60. https://doi.org/10.1177/0363546512453293.CrossRefPubMed

39.

Alsousou J, Handley R, Hulley P, Thompson M, McNally E, Harrison P, et al. Platelet rich plasma in accelerated achilles tendon regeneration: a randomized controlled trial. Orthop Proc. 2012;94-B(SUPP_XXXVI):6. https://doi.org/10.1302/1358-992x.94bsupp_xxxvi.Bors2011-006.CrossRef

40.

• De Carli A, Lanzetti RM, Ciompi A, Lupariello D, Vadala A, Argento G, et al. Can platelet-rich plasma have a role in Achilles tendon surgical repair? Knee Surg Sports Traumatol Arthrosc. 2016;24(7):2231–7. https://doi.org/10.1007/s00167-015-3580-1 Evaluated 30 patients surgically treated for Achilles tendon ruptures with and without adjunctive PRP injections. There were no differences in VAS, FAOS, and VISA-A scores and no clinical difference in functional tests between the groups. MRI with contrast evaluation at 6 months postoperatively did show less signal enhancement in the PRP group compared to the control group which could indirectly represent improved tendon remodeling, but this did not result in appreciable clinical differences. CrossRef

41.

Schepull T, Kvist J, Norrman H, Trinks M, Berlin G, Aspenberg P. Autologous platelets have no effect on the healing of human Achilles tendon ruptures: a randomized single-blind study. Am J Sports Med. 2011;39(1):38–47. https://doi.org/10.1177/0363546510383515.CrossRefPubMed

42.

Kaniki N, Willits K, Mohtadi NG, Fung V, Bryant D. A retrospective comparative study with historical control to determine the effectiveness of platelet-rich plasma as part of nonoperative treatment of acute Achilles tendon rupture. Arthroscopy. 2014;30(9):1139–45. https://doi.org/10.1016/j.arthro.2014.04.086.CrossRefPubMed

43.

Neufeld SK, Cerrato R. Plantar fasciitis: evaluation and treatment. J Am Acad Orthop Surg. 2008;16(6):338–46.CrossRef

44.

David JA, Sankarapandian V, Christopher PR, Chatterjee A, Macaden AS. Injected corticosteroids for treating plantar heel pain in adults. The Cochrane Database Syst Rev 2017;6:Cd009348. https://doi.org/10.1002/14651858.CD009348.pub2.

45.

Genc H, Saracoglu M, Nacir B, Erdem HR, Kacar M. Long-term ultrasonographic follow-up of plantar fasciitis patients treated with steroid injection. Joint, Bone, Spine : revue du rhumatisme. 2005;72(1):61–5. https://doi.org/10.1016/j.jbspin.2004.03.006.CrossRef

46.

Dorotka R, Sabeti M, Jimenez-Boj E, Goll A, Schubert S, Trieb K. Location modalities for focused extracorporeal shock wave application in the treatment of chronic plantar fasciitis. Foot Ankle Int. 2006;27(11):943–7. https://doi.org/10.1177/107110070602701113.CrossRefPubMed

47.

Jain SK, Suprashant K, Kumar S, Yadav A, Kearns SR. Comparison of plantar fasciitis injected with platelet-rich plasma vs corticosteroids. Foot Ankle Int. 2018;39(7):780–6. https://doi.org/10.1177/1071100718762406.CrossRefPubMed

48.

Acosta-Olivo C, Elizondo-Rodriguez J, Lopez-Cavazos R, Vilchez-Cavazos F, Simental-Mendia M, Mendoza-Lemus O. Plantar fasciitis-a comparison of treatment with intralesional steroids versus platelet-rich plasma a randomized, blinded study. J Am Podiatr Med Assoc. 2017;107(6):490–6. https://doi.org/10.7547/15-125.CrossRefPubMed

49.

Vahdatpour B, Kianimehr L, Moradi A, Haghighat S. Beneficial effects of platelet-rich plasma on improvement of pain severity and physical disability in patients with plantar fasciitis: a randomized trial. Adv Biomed Res. 2016;5:179. https://doi.org/10.4103/2277-9175.192731.CrossRefPubMedPubMedCentral

50.

Jain K, Murphy PN, Clough TM. Platelet rich plasma versus corticosteroid injection for plantar fasciitis: a comparative study. Foot (Edinburgh, Scotland). 2015;25(4):235–7. https://doi.org/10.1016/j.foot.2015.08.006.CrossRef

51.

Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int. 2014;35(4):313–8. https://doi.org/10.1177/1071100713519778.CrossRefPubMed

52.

• Singh P, Madanipour S, Bhamra JS, Gill I. A systematic review and meta-analysis of platelet-rich plasma versus corticosteroid injections for plantar fasciopathy. Int Orthop. 2017;41(6):1169–81. https://doi.org/10.1007/s00264-017-3470-x The pooled data showed that PRP resulted in significant improvement over corticosteroid in VAS and AOFAS scores at 3 months, but no difference in pain or function scores at 1-, 6-, or 12-month follow-up. With the data available it is uncertain whether the proposed limited benefit of PRP for the treatment of chronic plantar fasciitis is enough to offset the cost implications.CrossRefPubMed

53.

Lee KB, Bai LB, Yoon TR, Jung ST, Seon JK. Second-look arthroscopic findings and clinical outcomes after microfracture for osteochondral lesions of the talus. Am J Sports Med 2009;37(Suppl 1):63s–70s. https://doi.org/10.1177/0363546509348471.CrossRef

54.

Becher C, Driessen A, Hess T, Longo UG, Maffulli N, Thermann H. Microfracture for chondral defects of the talus: maintenance of early results at midterm follow-up. Knee Surg Sports Traumatol Arthroscopy. 2010;18(5):656–63. https://doi.org/10.1007/s00167-009-1036-1.CrossRef

55.

• Guney A, Akar M, Karaman I, Oner M, Guney B. Clinical outcomes of platelet rich plasma (PRP) as an adjunct to microfracture surgery in osteochondral lesions of the talus. Knee Surg Sports Traumatol Arthrosc. 2015;23(8):2384–9. https://doi.org/10.1007/s00167-013-2784-5 Randomized prospective study comparing patients treated with microfracture surgery alone versus microsurgery combined with PRP. At an average follow-up of 16.2 months, the authors found that both groups had significantly improved clinical outcomes, but the PRP group had superior outcomes to the microfracture-only group. Of note study only involved OLT’s less than 20mm in diameter.CrossRefPubMed

56.

Chuckpaiwong B, Berkson EM, Theodore GH. Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases. Arthroscopy. 2008;24(1):106–12. https://doi.org/10.1016/j.arthro.2007.07.022.CrossRefPubMed

57.

Choi WJ, Park KK, Kim BS, Lee JW. Osteochondral lesion of the talus: is there a critical defect size for poor outcome? Am J Sports Med. 2009;37(10):1974–80. https://doi.org/10.1177/0363546509335765.CrossRefPubMed

58.

Gormeli G, Karakaplan M, Gormeli CA, Sarikaya B, Elmali N, Ersoy Y. Clinical effects of platelet-rich plasma and hyaluronic acid as an additional therapy for talar osteochondral lesions treated with microfracture surgery: a prospective randomized clinical trial. Foot Ankle Int. 2015;36(8):891–900. https://doi.org/10.1177/1071100715578435.CrossRefPubMed

59.

Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40(3):534–41. https://doi.org/10.1177/0363546511431238.CrossRefPubMed

60.

Muehleman C, Bareither D, Huch K, Cole AA, Kuettner KE. Prevalence of degenerative morphological changes in the joints of the lower extremity. Osteoarthr Cartil. 1997;5(1):23–37.CrossRef

61.

Cushnaghan J, Dieppe P. Study of 500 patients with limb joint osteoarthritis. I. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis. 1991;50(1):8–13.CrossRef

62.

Dai WL, Zhou AG, Zhang H, Zhang J. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a meta-analysis of randomized controlled trials. Arthroscopy 2017;33(3):659–70.e1. https://doi.org/10.1016/j.arthro.2016.09.024.CrossRef

63.

Ornetti P, Nourissat G, Berenbaum F, Sellam J, Richette P, Chevalier X. Does platelet-rich plasma have a role in the treatment of osteoarthritis? Joint Bone Spine : revue du rhumatisme. 2016;83(1):31–6. https://doi.org/10.1016/j.jbspin.2015.05.002.CrossRef

64.

Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, Cenacchi A et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):472–479. https://doi.org/10.1007/s00167-009-0940-8.CrossRef

65.

• Repetto I, Biti B, Cerruti P, Trentini R, Felli L. Conservative treatment of ankle osteoarthritis: can platelet-rich plasma effectively postpone surgery? J Foot Ankle Surg. 2017;56(2):362–5. https://doi.org/10.1053/j.jfas.2016.11.015 Evaluated 20 patients with symptomatic ankle OA after four weekly PRP injections. At an average follow-up of 17.7 months, the authors found significant improvements in pain, function, and patient satisfaction. CrossRefPubMed

66.

Fukawa T, Yamaguchi S, Akatsu Y, Yamamoto Y, Akagi R, Sasho T. Safety and efficacy of intra-articular injection of platelet-rich plasma in patients with ankle osteoarthritis. Foot Ankle Int. 2017;38(6):596–604. https://doi.org/10.1177/1071100717700377.CrossRefPubMed

67.

Celotti F, Colciago A, Negri-Cesi P, Pravettoni A, Zaninetti R, Sacchi MC. Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: role of platelet-derived growth factor and transforming growth factor-beta. Wound Repair Regen. 2006;14(2):195–202. https://doi.org/10.1111/j.1743-6109.2006.00110.x.CrossRefPubMed

68.

Casati L, Celotti F, Negri-Cesi P, Sacchi MC, Castano P, Colciago A. Platelet derived growth factor (PDGF) contained in platelet rich plasma (PRP) stimulates migration of osteoblasts by reorganizing actin cytoskeleton. Cell Adhes Migr. 2014;8(6):595–602. https://doi.org/10.4161/19336918.2014.972785.CrossRef

69.

Wei LC, Lei GH, Sheng PY, Gao SG, Xu M, Jiang W, et al. Efficacy of platelet-rich plasma combined with allograft bone in the management of displaced intra-articular calcaneal fractures: a prospective cohort study. J Orthop Res. 2012;30(10):1570–6. https://doi.org/10.1002/jor.22118.CrossRefPubMed

70.

Bibbo C, Bono CM, Lin SS. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv. 2005;14(1):17–22.PubMed

71.

SanGiovanni TP, Kiebzak GM. Prospective randomized evaluation of intraoperative application of autologous platelet-rich plasma on surgical site infection or delayed wound healing. Foot Ankle Int. 2016;37(5):470–7. https://doi.org/10.1177/1071100715623994.CrossRefPubMed

72.

Kane JM, Costanzo JA, Raikin SM. The efficacy of platelet-rich plasma for incision healing after total ankle replacement using the agility total ankle replacement system. Foot Ankle Int. 2016;37(4):373–7. https://doi.org/10.1177/1071100715619681.CrossRefPubMed

73.

Martinez-Zapata MJ, Marti-Carvajal AJ, Sola I, Exposito JA, Bolibar I, Rodriguez L et al. Autologous platelet-rich plasma for treating chronic wounds. The Cochrane Database Syst Rev 2016(5):Cd006899. https://doi.org/10.1002/14651858.CD006899.pub3.

74.

Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg. 2017;38:206–11. https://doi.org/10.1016/j.avsg.2016.04.023.CrossRefPubMed

75.

Babaei V, Afradi H, Gohardani HZ, Nasseri F, Azarafza M, Teimourian S. Management of chronic diabetic foot ulcers using platelet-rich plasma. J Wound Care. 2017;26(12):784–7. https://doi.org/10.12968/jowc.2017.26.12.784.CrossRefPubMed

76.

Chahla J, Cinque ME, Piuzzi NS, Mannava S, Geeslin AG, Murray IR, et al. A call for standardization in platelet-rich plasma preparation protocols and composition reporting: a systematic review of the clinical orthopaedic literature. J Bone Joint Surg. 2017;99(20):1769–79. https://doi.org/10.2106/jbjs.16.01374.CrossRefPubMed

Titel: Platelet-rich plasma in the foot and ankle
verfasst von: Peter R. Henning
Benjamin J. Grear
Publikationsdatum: 26.09.2018
Verlag: Springer US
Erschienen in: Current Reviews in Musculoskeletal Medicine / Ausgabe 4/2018
Elektronische ISSN: 1935-9748
DOI: https://doi.org/10.1007/s12178-018-9522-z

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Platelet-rich plasma in the foot and ankle

Abstract

Purpose of review

Recent findings

Summary

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Update Orthopädie und Unfallchirurgie

Springer Medizin

Abstract

Purpose of review

Recent findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2018

Platelet-Rich Plasma for Elbow Pathologies: a Descriptive Review of Current Literature

Management of Midfoot Fractures and Dislocations

Clinical Update: Why PRP Should Be Your First Choice for Injection Therapy in Treating Osteoarthritis of the Knee

Evolution in Management of Tibial Pilon Fractures

Management of Posttraumatic Ankle Arthritis: Literature Review

Platelet-Rich Plasma and the Knee—Applications in Orthopedic Surgery

Arthropedia

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Ärztliche Empathie hilft gegen Rückenschmerzen

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Vorsicht mit hohen NSAR-Dosen bei ankylosierender Spondylitis!

Brustkrebs in der Vorgeschichte macht Gelenkersatz komplikationsträchtiger

Update Orthopädie und Unfallchirurgie